Alessandra Bragonzi - Concepedia

Author

Alessandra Bragonzi

Vita-Salute San Raffaele University ORCID

Also Known As

A BRAGONZI, A Bragonzi, A. Bragonzi, Alessandra Bragonzi, Bragonzi Alessandra, Bragonzi, Alessandra

172

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Vita-Salute San Raffaele University Istituti di Ricovero e Cura a Carattere Scientifico Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele University of Milan San Raffaele University of Rome

About

Alessandra Bragonzi is an author at Vita-Salute San Raffaele University specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	36	2.2K
2	Health Sciences	5	5	282
3	Engineering	2	2	177
4	Natural Sciences	2	2	241
5	Allergy	1	1	165

Alessandra Bragonzi

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
<i>Pseudomonas aeruginosa</i> Microevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence Alessandra Bragonzi, Moira Paroni, Alessandro Nonis, American Journal of Respiratory and Critical Care Medicine	2009	251
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection Fabrizia Minandri, Francesco Imperi, Emanuela Frangipani, Infection and Immunity	2016	222
Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection Rossella Baldan, Cristina Cigana, Francesca Testa, PLoS ONE Pathogenic MicrobiologyInflammatory Lung DiseaseKlebsiella PneumoniaeStaphylococcus AureusBacterial Pathogenesis	2014	165
Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs Alessandra Bragonzi, Alessandra Boletta, Alessandra Biffi, Gene Therapy Tissue EngineeringCell-based Drug DeliveryLipid PreparationSystemic Gene DeliveryEngineering	1999	161
Repurposing the antimycotic drug flucytosine for suppression of<i>Pseudomonas aeruginosa</i>pathogenicity Francesco Imperi, Francesco Massai, Marcella Facchini, Proceedings of the National Academy of Sciences	2013	155
<i>R</i><i>othia mucilaginosa</i>is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease Charlotte Rigauts, Juliana Aizawa, Steven Taylor, European Respiratory Journal	2021	150
Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs Alessandra Bragonzi, Giorgia Dina, Antonello Villa, Gene Therapy Inflammatory Lung DiseaseTransgene ExpressionNatural SciencesMolecular BiologyDna Replication	2000	148
Nonmucoid<i>Pseudomonas aeruginosa</i>Expresses Alginate in the Lungs of Patients with Cystic Fibrosis and in a Mouse Model Alessandra Bragonzi, Dieter Worlitzsch, Gerald B. Pier, The Journal of Infectious Diseases	2005	140
Pseudomonas aeruginosa Exploits Lipid A and Muropeptides Modification as a Strategy to Lower Innate Immunity during Cystic Fibrosis Lung Infection Cristina Cigana, Laura Curcurù, Maria R. Leone, PLoS ONE Cf Lung InfectionInflammatory Lung DiseaseExploits Lipid ALung InflammationInnate Immune System	2009	134
Modelling Co-Infection of the Cystic Fibrosis Lung by Pseudomonas aeruginosa and Burkholderia cenocepacia Reveals Influences on Biofilm Formation and Host Response Alessandra Bragonzi, Ilaria Farulla, Moira Paroni, PLoS ONE Medical MicrobiologyPathogenic MicrobiologyBiofilm FormationAntimicrobial SusceptibilityMedicine	2012	117

Page 1